WT
NVCR icon

Whittier Trust’s NovoCure NVCR Stock Holding History

Whittier Trust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-740
Closed -$54.3K – 1630
2022
Q4 		$54.3K Buy
+740
New +$55.7K ﹤0.01% 946
2020
Q2 		– Sell
-200
Closed -$13K – 1470
2020
Q1 		$13K Buy
+200
New +$15.8K ﹤0.01% 1068
2019
Q2 		– Sell
-13
Closed -$1K – 1432
2019
Q1 		$1K Buy
+13
New +$626 ﹤0.01% 1316

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Whittier Trust's NVCR Position: Q1 2023 in Review

Whittier Trust sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 740 shares — an estimated $54.3K sold.

Whittier Trust first reported a position in NVCR in Q1 2019 and held it in 3 quarters. The position peaked at $54.3K in Q4 2022. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • Whittier Trust reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • Whittier Trust sold 740 NovoCure shares in Q1 2023, an estimated $54.3K.
  • Whittier Trust first reported a position in NovoCure in Q1 2019 and held it in 3 quarters.
  • Whittier Trust's NovoCure position peaked at $54.3K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on Whittier Trust's 13F filing for Q1 2023, filed 21 Apr 2023.